Rein Therapeutics, Inc. Number of Reportable Segments
Rein Therapeutics, Inc. (RNTX) reported Number of Reportable Segments of 1 Segment for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-03-26
- Rein Therapeutics, Inc. number of reportable segments for the quarter ending 2025-03-31 was 1.00 Segment.
- Rein Therapeutics, Inc. number of reportable segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
- Rein Therapeutics, Inc. number of reportable segments for fiscal 2024 was 1.00 Segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-26 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |